HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome.

Abstract
This Finnish population-based study, mean age 46 years, evaluates the association of high-sensitivity C-reactive protein (hs-CRP), interleukin-1 receptor antagonist (IL-1Ra), and adiponectin with the NCEP and IDF definitions of metabolic syndrome (MetS). Adiponectin levels were higher, hs-CRP and IL-1Ra levels lower in subjects without MetS compared to subjects with MetS. If MetS was present according to both IDF and NCEP criteria, BMI, waist, triglycerides, hs-CRP, and IL-1Ra were significantly higher compared to subjects who had MetS according to either only IDF or only NCEP criteria. The hs-CRP, IL-1Ra, and adiponectin linearly correlated with the number of the components of MetS according to both definitions. Decreased levels of adiponectin and increased levels of hs-CRP and IL-1Ra are tightly associated with the components of MetS. Individuals who had MetS according to both criteria had the most adverse changes in cardiovascular risk factors.
AuthorsJuha Saltevo, Mauno Vanhala, Hannu Kautiainen, Esko Kumpusalo, Markku Laakso
JournalMediators of inflammation (Mediators Inflamm) Vol. 2007 Pg. 93573 ( 2007) ISSN: 1466-1861 [Electronic] United States
PMID18288276 (Publication Type: Journal Article)
Chemical References
  • Adiponectin
  • Biomarkers
  • Interleukin 1 Receptor Antagonist Protein
  • C-Reactive Protein
Topics
  • Adiponectin (blood)
  • Adult
  • Aged
  • Biomarkers
  • C-Reactive Protein (biosynthesis)
  • Female
  • Humans
  • Inflammation
  • Interleukin 1 Receptor Antagonist Protein (blood)
  • Male
  • Metabolic Syndrome (blood)
  • Middle Aged
  • Risk Factors
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: